|
|
|
Originator Org.- |
|
|
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.CH |
First Approval Date28 Apr 1998 |
[Translation] JC002 Comparative Pharmacokinetics Clinical Trial
主要研究目的:评价空腹状态下JC002药代动力学的特性。
次要研究目的:评价JC002服用口感与已上市对照制剂是否存在差异;并观察JC002在健康成人受试者中的安全性。
[Translation] Main research purpose: To evaluate the pharmacokinetic properties of JC002 in the fasting state.
Secondary research purpose: To evaluate whether there is any difference in the taste of JC002 and the marketed control preparation; and to observe the safety of JC002 in healthy adult subjects.
100 Clinical Results associated with Beijing Jiacheng Biomedical Technology Development Co., Ltd
0 Patents (Medical) associated with Beijing Jiacheng Biomedical Technology Development Co., Ltd
100 Deals associated with Beijing Jiacheng Biomedical Technology Development Co., Ltd
100 Translational Medicine associated with Beijing Jiacheng Biomedical Technology Development Co., Ltd